Analyzing Genetic Variants in Parkinson's Disease Across Different Ancestries
Author Information
Author(s): Hong Samantha, Koretsky Mathew J., Lichtenberg Jens, Leonard Hampton, Pitz Vanessa
Primary Institution: Global Parkinson’s Genetics Program (GP2)
Hypothesis
This study evaluated genotyping success of the NeuroBooster array (NBA) and determined the frequencies of pathogenic variants across ancestries.
Conclusion
The study confirms that established Parkinson's disease genes are pathogenic and emphasizes the importance of diverse research in understanding the disease.
Supporting Evidence
- 25 of the 34 pathogenic variants were typed by the NBA array.
- Genes with high confidence for causing PD had more pathogenic variants.
- Research highlights the importance of ancestrally diverse studies in PD genetics.
Takeaway
Researchers looked at genetic changes that can cause Parkinson's disease in many different groups of people to see how common these changes are.
Methodology
The study analyzed the presence and allele frequency of 34 pathogenic variants in 28,710 PD cases, 9,614 other neurodegenerative disorder cases, and 15,821 controls across 11 ancestries.
Potential Biases
The reliance on the ClinVar database may introduce bias as it primarily reflects studies published in European populations.
Limitations
Many pathogenic variants were imputed rather than directly typed, and the sample sizes across ancestries were inconsistent.
Participant Demographics
The study included 28,710 PD cases, 9,614 other neurodegenerative disorder cases, and 15,821 controls across 11 ancestry groups.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website